Literature DB >> 11163643

Arenavirus nucleocapsid protein displays a transcriptional antitermination activity in vivo.

M A Tortorici1, C G Albariño, D M Posik, P D Ghiringhelli, M E Lozano, R Rivera Pomar, V Romanowski.   

Abstract

RNA polymerase pausing and transcriptional antitermination regulates gene activity in several systems. In arenavirus infected cells the switch from transcription to replication is subjected to a hairpin-dependent termination and requires protein synthesis to bypass this signal. The transcriptional antitermination control by Junín virus nucleocapsid protein N, has been demonstrated in vivo by infecting BHK-21 cells expressing this viral protein in the presence of translation inhibitors. This is the first demonstration in vivo of a transcriptional antitermination control in arenavirus-infected cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11163643     DOI: 10.1016/s0168-1702(00)00222-7

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  25 in total

1.  Genomic features of attenuated Junín virus vaccine strain candidate.

Authors:  Sandra Elizabeth Goñi; Javier Alonso Iserte; Ana Maria Ambrosio; Victor Romanowski; Pablo Daniel Ghiringhelli; Mario Enrique Lozano
Journal:  Virus Genes       Date:  2006-02       Impact factor: 2.332

2.  Lassa virus nucleoprotein mutants generated by reverse genetics induce a robust type I interferon response in human dendritic cells and macrophages.

Authors:  Xavier Carnec; Sylvain Baize; Stéphanie Reynard; Laure Diancourt; Valérie Caro; Noel Tordo; Michèle Bouloy
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

3.  Molecular analysis of the virulence attenuation process in Junín virus vaccine genealogy.

Authors:  Sandra Elizabeth Goñi; Javier Alonso Iserte; Betina Inés Stephan; Cristina Silvia Borio; Pablo Daniel Ghiringhelli; Mario Enrique Lozano
Journal:  Virus Genes       Date:  2010-02-11       Impact factor: 2.332

Review 4.  Epidemiology and pathogenesis of Bolivian hemorrhagic fever.

Authors:  Michael Patterson; Ashley Grant; Slobodan Paessler
Journal:  Curr Opin Virol       Date:  2014-03-15       Impact factor: 7.090

5.  Rescue from cloned cDNAs and in vivo characterization of recombinant pathogenic Romero and live-attenuated Candid #1 strains of Junin virus, the causative agent of Argentine hemorrhagic fever disease.

Authors:  Sebastien F Emonet; Alexey V Seregin; Nadezhda E Yun; Allison L Poussard; Aida G Walker; Juan C de la Torre; Slobodan Paessler
Journal:  J Virol       Date:  2010-12-01       Impact factor: 5.103

6.  Dual role of the lymphocytic choriomeningitis virus intergenic region in transcription termination and virus propagation.

Authors:  Daniel D Pinschewer; Mar Perez; Juan Carlos de la Torre
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

7.  Rescue of a recombinant Machupo virus from cloned cDNAs and in vivo characterization in interferon (αβ/γ) receptor double knockout mice.

Authors:  Michael Patterson; Alexey Seregin; Cheng Huang; Olga Kolokoltsova; Jennifer Smith; Milagros Miller; Jeanon Smith; Nadezhda Yun; Allison Poussard; Ashley Grant; Bersabeh Tigabu; Aida Walker; Slobodan Paessler
Journal:  J Virol       Date:  2013-11-27       Impact factor: 5.103

8.  Tacaribe virus Z protein interacts with the L polymerase protein to inhibit viral RNA synthesis.

Authors:  Rodrigo Jácamo; Nora López; Maximiliano Wilda; María T Franze-Fernández
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  A substitution in the transmembrane region of the glycoprotein leads to an unstable attenuation of Machupo virus.

Authors:  Michael Patterson; Takaaki Koma; Alexey Seregin; Cheng Huang; Milagros Miller; Jennifer Smith; Nadezhda Yun; Jeanon Smith; Slobodan Paessler
Journal:  J Virol       Date:  2014-07-16       Impact factor: 5.103

Review 10.  Reverse genetics approaches to combat pathogenic arenaviruses.

Authors:  Juan C de la Torre
Journal:  Antiviral Res       Date:  2008-09-07       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.